series-a
Stage
1
Investors
About
CellVoyant develops AI-driven software that analyzes label-free cell images to predict current and future cell states and simulates cell process conditions to optimize decisions in the development and manufacturing of cell-based therapeutics.
Explore CellVoyant's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.